T cell engagers are being explored as a potential therapeutic approach, particularly in the treatment of cancer and autoimmune diseases. Research in this area is ongoing, with developments in targeting tumor-associated antigens and creating multispecific T-cell engagers. The emergence of T cell engagers as a therapeutic modality is expected to continue, with potential advancements anticipated in the near future.